AgentsNEWPharmaTestingHuman in loop: yes
Anthropic reports early drug-development results with six partners using Claude
Anthropic says Claude caught all 11 issues human reviewers found in Enveda's 1,061 pages of manufacturing documents, flagged seven they missed, and cut review time 89%. It says most of the work is still preclinical.
Why it matters: Paperwork, not just molecule design, is where Anthropic shows gains; it says Enveda's chemists spent up to 75% of their time on it. The Hacker News thread drew 222 points.
From Drop #051 · Wed, Oct 28 · Morning